What's happening
Writing a plain-English summary… Track this bill to get it by email.
Why it matters
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Sponsors
History
- Signed chap.357
- Delivered to governor
- Returned to senate
- Passed assembly
- Ordered to third reading rules cal.712
- Substituted for A933B
- Referred to codes
- Delivered to assembly
- Passed senateVote 61–0
- Ordered to third reading cal.1217
- Print number 696b
- Amend and recommit to rules
Show 4 earlier actions
- Committee discharged and committed to rules
- Print number 696a
- Amend (t) and recommit to higher education
- Referred to higher education
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Restricts retail sale of dextromethorphan, commonly known as DXM
Assembly Floor Calendar · Sponsor Ellen C. Jaffee
Full text
The text isn't available here yet. Check nysenate.gov.
Sponsor's memo
BILL NUMBER:S696B
Title of bill
An act to amend the general business law, in relation to restricting access to dextromethorphan, commonly known as "dxm"
Purpose or general idea of bill
To prohibit the sale of any product or products containing the active ingredient dextromethorphan to persons under the age of eighteen.
Summary of specific provisions
Section 1 amends the General Business Law by adding a new section 391-s to prohibit any retail establishment from selling any product or products containing the active ingredient dextromethorphan to persons under the age of eighteen without a valid prescription. The bill also requires proof of legal age to purchase such products and subjects any retail establishment that violates the provisions of this section of law to a fine of two hundred and fifty dollars. In addition, the bill defines the term retail establishment to mean every vendor that in the regular course of business sells products containing dextromethorphan at retail directly to the public including, but not limited to, pharmacies, grocery stores, and other retail stores.
Section 2 states that this act would take effect on the one hundred eightieth day following enactment.
Justification
The abuse of dextromethorphan (DXM), now being called the next crystal meth, is increasing among teens. Since the 1950s, DXM has been used primarily as a safe over-the-counter (OTC) medicine. However, in recent years, an increasing number of teens have been abusing the substance because of its easy accessibility. As an OTC drug, there are no restrictions as to who can purchase medicine containing DXM or how much can be purchased. A significant number of teens are under the misconception that since it is an OTC medicine, it is therefore harmless. The reverse is true. Abuse of DXM has been found to cause serious side-effects and even death. The effects vary with the amount taken and include confusion, dizziness, double or blurred vision, slurred speech, vomiting, rapid heartbeat, numbness of fingers and toes, and disorientation. Extremely high doses of DXM can induce a hallucinatory state that can lead to accidental deaths. Teens abuse DXM to experience the visual hallucinations and sensations similar to other dissociative anesthetics like PCP and Ketamine. The age restriction this bill imposes will help to reduce the potential dangers of DXM to our teen population.
Prior legislative history
S.6085 of 2011-2012; Referred to Higher Education.
Fiscal implications
None.
Effective date
This act would take effect on the one hundred eightieth day after it becomes a law.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.